Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for KURA

Stock Name	Kura Oncology Inc
Ticker	KURA(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US50127T1097
LEI	5493005QORQTZCZYOP39

Show aggregate KURA holdings

News associated with KURA

Kura Oncology (NASDAQ:KURA) Shares Gap Up After Insider Buying Activity: Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $8.01, but opened at $8.62. Kura Oncology shares last traded at $8.36, with a volume of 819,759 shares changing hands. Specifically, CEO Troy Edward Wilson purchased 50,000 shares of […] - 2025-09-11 02:33:48
Biotech Stocks Rally After-Hours On Trial Updates, Insider Buys, And Conference Buzz: (RTTNews) - Biotech stocks lit up the after-hours session on September 9, 2025, with several small- and mid-cap names posting sharp gains following fresh clinical updates, insider buying, and investor conference appearances. Companies like Immutep, Nautilus Biotechnology, Pliant - 2025-09-10 01:36:37
Kura Oncology, Inc. (NASDAQ:KURA) Receives $24.10 Consensus Price Target from Brokerages: Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the fifteen research firms that are covering the stock, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation, ten have assigned a buy recommendation and one has assigned a strong […] - 2025-09-09 02:46:57
Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of “Moderate Buy” from Analysts: Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has earned an average rating of “Moderate Buy” from the fourteen research firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to […] - 2025-08-12 03:01:02
Kura Oncology, Inc. (NASDAQ:KURA) Shares Bought by Cwm LLC: Cwm LLC boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 892.8% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 28,353 shares of the company’s stock after acquiring an additional 25,497 shares during the quarter. Cwm LLC’s holdings in […] - 2025-07-28 05:02:47
Kura Oncology, Inc. (NASDAQ:KURA) Receives $24.50 Average PT from Analysts: Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy […] - 2025-07-21 02:45:06
SG Americas Securities LLC Decreases Stake in Kura Oncology, Inc. (NASDAQ:KURA): SG Americas Securities LLC cut its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 15.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,121 shares of the company’s stock after selling 7,918 shares during the period. SG […] - 2025-06-27 04:20:58
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 9,050 Shares of Kura Oncology, Inc. (NASDAQ:KURA): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 7.4% in the 4th quarter, HoldingsChannel reports. The fund owned 131,718 shares of the company’s stock after buying an additional 9,050 shares during the period. UBS AM a distinct […] - 2025-06-10 04:20:48
Hennion & Walsh Asset Management Inc. Has $791,000 Holdings in Kura Oncology, Inc. (NASDAQ:KURA): Hennion & Walsh Asset Management Inc. lowered its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 2.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 119,816 shares of the company’s stock after selling 3,099 shares during the […] - 2025-06-08 05:53:09
JMP Securities Reaffirms “Market Outperform” Rating for Kura Oncology (NASDAQ:KURA): JMP Securities restated their market outperform rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $28.00 target price on the stock. Other equities research analysts have also issued reports about the stock. Barclays lowered their price target on shares of Kura Oncology […] - 2025-06-05 04:25:02
Man Group plc Takes $163,000 Position in Kura Oncology, Inc. (NASDAQ:KURA): Man Group plc acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the fourth quarter, HoldingsChannel reports. The fund acquired 18,705 shares of the company’s stock, valued at approximately $163,000. Other institutional investors have also recently bought and sold shares of the company. Millennium Management LLC lifted its position […] - 2025-05-29 06:22:57
Kura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Two Sigma Advisers LP: Two Sigma Advisers LP grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 147.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 242,200 shares of the company’s stock after acquiring an additional 144,201 […] - 2025-05-29 05:16:54
Millennium Management LLC Increases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA): Millennium Management LLC boosted its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 180.1% during the fourth quarter, HoldingsChannel reports. The firm owned 2,367,148 shares of the company’s stock after buying an additional 1,521,954 shares during the period. Millennium Management LLC’s holdings in Kura Oncology were worth $20,618,000 at the end of the […] - 2025-05-21 05:46:49
Mizuho Has Lowered Expectations for Kura Oncology (NASDAQ:KURA) Stock Price: Kura Oncology (NASDAQ:KURA – Get Free Report) had its price objective decreased by stock analysts at Mizuho from $32.00 to $30.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s target price indicates a potential upside of 370.22% from the company’s […] - 2025-05-21 05:06:53
BNP Paribas Financial Markets Has $1.43 Million Position in Kura Oncology, Inc. (NASDAQ:KURA): BNP Paribas Financial Markets boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 969.9% in the fourth quarter, Holdings Channel reports. The firm owned 163,559 shares of the company’s stock after purchasing an additional 148,272 shares during the period. BNP Paribas Financial Markets’ holdings in Kura Oncology were worth $1,425,000 […] - 2025-05-19 04:36:55
Wells Fargo & Company MN Has $305,000 Holdings in Kura Oncology, Inc. (NASDAQ:KURA): Wells Fargo & Company MN grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 48.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,989 shares of the company’s stock after acquiring an additional 11,427 shares […] - 2025-05-07 06:20:47
Kura Oncology, Inc. (NASDAQ:KURA) Shares Purchased by MetLife Investment Management LLC: MetLife Investment Management LLC boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 6.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 44,828 shares of the company’s stock after acquiring an additional 2,776 shares during the period. MetLife Investment Management LLC’s holdings in Kura Oncology were worth […] - 2025-05-07 05:28:47
Kura Oncology (NASDAQ:KURA) Given Buy Rating at HC Wainwright: HC Wainwright restated their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $40.00 price objective on the stock. Several other brokerages also recently weighed in on KURA. JMP Securities reaffirmed a “market outperform” rating and set a $28.00 […] - 2025-04-29 04:28:55
Kura Oncology, Inc. (NASDAQ:KURA) Shares Sold by Corebridge Financial Inc.: Corebridge Financial Inc. reduced its stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 7.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 36,050 shares of the company’s stock after selling 2,721 shares during the quarter. Corebridge Financial Inc.’s holdings […] - 2025-04-11 04:54:48
Kura Oncology (NASDAQ:KURA) Given Outperform Rating at Wedbush: Kura Oncology (NASDAQ:KURA – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research note issued to investors on Tuesday,RTT News reports. They currently have a $36.00 price objective on the stock. A number of other equities analysts have also recently weighed in on KURA. UBS Group dropped their price target […] - 2025-04-10 04:54:43
Kura Oncology, Inc. (NASDAQ:KURA) Stock Position Increased by Teacher Retirement System of Texas: Teacher Retirement System of Texas lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 19.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 13,749 shares of the company’s stock after acquiring an additional 2,285 shares during the quarter. Teacher Retirement System of Texas’ holdings in Kura Oncology were worth […] - 2025-04-03 04:16:48
Financial Comparison: Kura Oncology (NASDAQ:KURA) & Repare Therapeutics (NASDAQ:RPTX): Kura Oncology (NASDAQ:KURA – Get Free Report) and Repare Therapeutics (NASDAQ:RPTX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations. Profitability This table compares Kura Oncology and […] - 2025-04-03 02:22:47
StockNews.com Upgrades Kura Oncology (NASDAQ:KURA) to “Buy”: StockNews.com upgraded shares of Kura Oncology (NASDAQ:KURA – Free Report) from a hold rating to a buy rating in a research report report published on Wednesday morning. KURA has been the subject of a number of other reports. Cantor Fitzgerald raised shares of Kura Oncology to a “strong-buy” rating in a research report on Tuesday, […] - 2025-03-27 05:00:50
Kura Oncology (NASDAQ:KURA) Stock Rating Lowered by StockNews.com: StockNews.com lowered shares of Kura Oncology (NASDAQ:KURA – Free Report) from a buy rating to a hold rating in a research note released on Tuesday. KURA has been the topic of a number of other research reports. Jefferies Financial Group lowered their target price on shares of Kura Oncology from $32.00 to $28.00 and set […] - 2025-03-19 04:52:47
20,331 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Bought by AlphaQuest LLC: AlphaQuest LLC acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 20,331 shares of the company’s stock, valued at approximately $177,000. Several other large investors have also recently added to […] - 2025-03-17 06:04:56
Rhumbline Advisers Purchases 1,923 Shares of Kura Oncology, Inc. (NASDAQ:KURA): Rhumbline Advisers boosted its position in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 2.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 99,991 shares of the company’s stock after acquiring an additional 1,923 shares during the period. Rhumbline Advisers’ holdings […] - 2025-03-07 07:20:52
Kura Oncology (NASDAQ:KURA) Raised to “Strong-Buy” at Cantor Fitzgerald: Kura Oncology (NASDAQ:KURA – Get Free Report) was upgraded by analysts at Cantor Fitzgerald to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports. Several other research firms have also recently commented on KURA. HC Wainwright restated a “buy” rating and set a $40.00 target price on shares of Kura Oncology […] - 2025-03-06 06:20:01
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) PT at $27.13: Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, eight have issued a buy recommendation and one has assigned a strong buy recommendation […] - 2025-02-21 04:46:47
Barclays PLC Has $3.23 Million Stock Position in Kura Oncology, Inc. (NASDAQ:KURA): Barclays PLC boosted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 104.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 165,484 shares of the company’s stock after purchasing an additional 84,563 shares during the period. Barclays PLC’s holdings in Kura […] - 2025-02-11 06:42:48
Jennison Associates LLC Acquires Shares of 71,497 Kura Oncology, Inc. (NASDAQ:KURA): Jennison Associates LLC acquired a new stake in Kura Oncology, Inc. (NASDAQ:KURA – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 71,497 shares of the company’s stock, valued at approximately $623,000. Several other large investors also recently added to or reduced their stakes in KURA. Moody Aldrich Partners LLC lifted its […] - 2025-02-08 07:05:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) KURA holdings

Date	Number of KURA Shares Held	Base Market Value of KURA Shares	Local Market Value of KURA Shares	Change in KURA Shares Held	Change in KURA Base Value	Current Price per KURA Share Held	Previous Price per KURA Share Held
2025-12-03 (Wednesday)	62,920	USD 753,152	USD 753,152	0	USD 52,852	USD 11.97	USD 11.13
2025-12-02 (Tuesday)	62,920	USD 700,300	USD 700,300	2,265	USD 6,407	USD 11.13	USD 11.44
2025-12-01 (Monday)	60,655	USD 693,893	USD 693,893	0	USD -42,459	USD 11.44	USD 12.14
2025-11-28 (Friday)	60,655	USD 736,352	USD 736,352	151	USD 10,909	USD 12.14	USD 11.99
2025-11-27 (Thursday)	60,504	USD 725,443	USD 725,443	0	USD 0	USD 11.99	USD 11.99
2025-11-26 (Wednesday)	60,504	USD 725,443	USD 725,443	453	USD 28,851	USD 11.99	USD 11.6
2025-11-25 (Tuesday)	60,051	USD 696,592	USD 696,592	755	USD 1,050	USD 11.6	USD 11.73
2025-11-24 (Monday)	59,296	USD 695,542	USD 695,542	151	USD 34,892	USD 11.73	USD 11.17
2025-11-21 (Friday)	59,145	USD 660,650	USD 660,650	0	USD 11,238	USD 11.17	USD 10.98
2025-11-20 (Thursday)	59,145	USD 649,412	USD 649,412	-600	USD -26,901	USD 10.98	USD 11.32
2025-11-19 (Wednesday)	59,745	USD 676,313	USD 676,313	150	USD 16,000	USD 11.32	USD 11.08
2025-11-18 (Tuesday)	59,595	USD 660,313	USD 660,313	900	USD 23,472	USD 11.08	USD 10.85
2025-11-17 (Monday)	58,695	USD 636,841	USD 636,841	300	USD -17,475	USD 10.85	USD 11.205

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of KURA by Blackrock for IE00BDZVHG35

Show aggregate share trades of KURA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 2,265 11.555 10.800 10.876 USD 24,633 8.80
2025-11-28 BUY 151 12.265 11.970 12.000 USD 1,812 8.77
2025-11-26 BUY 453 12.195 11.420 11.498 USD 5,208 8.74
2025-11-26 BUY 453 12.195 11.420 11.498 USD 5,208 8.74
2025-11-25 BUY 755 11.970 11.520 11.565 USD 8,732 8.73
2025-11-24 BUY 151 11.840 11.200 11.264 USD 1,701 8.71
2025-11-20 SELL -600 11.879 10.930 11.025 USD -6,615 8.69 Loss of -1,402 on sale
2025-11-19 BUY 150 11.810 11.010 11.090 USD 1,664 8.67
2025-11-18 BUY 900 11.340 10.500 10.584 USD 9,526 8.66
2025-11-17 BUY 300 11.500 10.770 10.843 USD 3,253 8.65
2025-11-14 BUY 150 12.490 10.700 10.879 USD 1,632 8.64
2025-11-12 BUY 150 11.310 10.610 10.680 USD 1,602 8.62
2025-11-10 BUY 150 10.500 9.950 10.005 USD 1,501 8.60
2025-11-06 BUY 150 10.412 9.865 9.920 USD 1,488 8.58
2025-11-04 BUY 151 10.170 8.830 8.964 USD 1,354 8.57
2025-10-30 BUY 755 10.672 10.200 10.247 USD 7,737 8.54
2025-10-29 BUY 302 10.260 10.735 10.687 USD 3,228 8.53
2025-10-22 SELL -600 9.280 9.650 9.613 USD -5,768 8.49 Loss of -673 on sale
2025-10-20 BUY 300 9.990 10.405 10.363 USD 3,109 8.48
2025-10-17 BUY 749 9.840 10.200 10.164 USD 7,613 8.47
2025-10-15 BUY 1,192 10.290 10.340 10.335 USD 12,319 8.46
2025-10-03 BUY 1,057 9.570 9.745 9.727 USD 10,282 8.44
2025-10-02 BUY 151 9.140 9.372 9.349 USD 1,412 8.44
2025-09-30 BUY 302 8.850 9.040 9.021 USD 2,724 8.43
2025-09-26 BUY 302 9.050 9.130 9.122 USD 2,755 8.43
2025-09-25 BUY 302 8.360 8.425 8.419 USD 2,542 8.43
2025-09-18 BUY 153 8.440 8.500 8.494 USD 1,300 8.43
2025-09-17 BUY 459 8.090 8.580 8.531 USD 3,916 8.43
2025-09-11 SELL -152 8.825 8.850 8.848 USD -1,345 8.43 Loss of -64 on sale
2025-09-10 BUY 304 8.170 8.900 8.827 USD 2,683 8.43
2025-07-17 SELL -300 6.600 6.695 6.686 USD -2,006 8.47 Profit of 535 on sale
2025-07-11 SELL -1,208 6.280 6.505 6.483 USD -7,831 8.53 Profit of 2,469 on sale
2025-07-02 BUY 8,360 5.810 5.995 5.976 USD 49,964 8.59
2025-06-25 BUY 302 5.800 5.970 5.953 USD 1,798 8.67
2025-06-20 BUY 4,513 5.850 6.110 6.084 USD 27,457 8.73
2025-06-11 BUY 274 6.920 7.110 7.091 USD 1,943 8.86
2025-06-10 BUY 274 6.810 7.020 6.999 USD 1,918 8.87
2025-06-04 SELL -137 6.450 6.650 6.630 USD -908 8.94 Profit of 317 on sale
2025-04-23 BUY 136 6.370 6.600 6.577 USD 894 9.81
2025-04-10 SELL -1,088 5.630 5.860 5.837 USD -6,351 10.20 Profit of 4,751 on sale
2025-04-08 SELL -136 5.620 6.120 6.070 USD -826 10.31 Profit of 576 on sale
2025-04-07 SELL -136 5.760 6.020 5.994 USD -815 10.36 Profit of 594 on sale
2025-04-04 SELL -685 5.890 6.160 6.133 USD -4,201 10.41 Profit of 2,930 on sale
2025-04-01 BUY 556 6.380 6.580 6.560 USD 3,647 10.51
2025-03-31 SELL -411 6.600 6.950 6.915 USD -2,842 10.55 Profit of 1,496 on sale
2025-03-21 BUY 3,380 7.840 8.040 8.020 USD 27,108 10.81
2025-03-14 SELL -2,032 7.140 7.490 7.455 USD -15,149 11.05 Profit of 7,306 on sale
2025-03-07 SELL -252 7.530 7.740 7.719 USD -1,945 11.33 Profit of 909 on sale
2025-03-04 SELL -127 7.330 7.430 7.420 USD -942 11.51 Profit of 519 on sale
2025-02-25 BUY 254 7.880 7.960 7.952 USD 2,020 11.84
2025-02-19 SELL -126 8.290 8.320 8.317 USD -1,048 12.12 Profit of 479 on sale
2025-02-13 BUY 375 8.280 8.500 8.478 USD 3,179 12.43
2025-02-12 BUY 125 8.350 8.390 8.386 USD 1,048 12.51
2025-02-11 BUY 500 8.340 8.850 8.799 USD 4,400 12.60
2024-12-30 SELL -3,449 8.510 8.670 8.654 USD -29,848 14.53 Profit of 20,278 on sale
2024-11-18 SELL -1,968 16.040 16.680 16.616 USD -32,700 17.51 Profit of 1,768 on sale
2024-11-08 SELL -131 17.680 17.960 17.932 USD -2,349 17.43 Loss of -66 on sale
2024-10-21 SELL -132 17.700 17.970 17.943 USD -2,368 0.00 Loss of -2,368 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	2,265	11.555	10.800	10.876	USD 24,633	8.80
2025-11-28	BUY	151	12.265	11.970	12.000	USD 1,812	8.77
2025-11-26	BUY	453	12.195	11.420	11.498	USD 5,208	8.74
2025-11-26	BUY	453	12.195	11.420	11.498	USD 5,208	8.74
2025-11-25	BUY	755	11.970	11.520	11.565	USD 8,732	8.73
2025-11-24	BUY	151	11.840	11.200	11.264	USD 1,701	8.71
2025-11-20	SELL	-600	11.879	10.930	11.025	USD -6,615	8.69 Loss of -1,402 on sale
2025-11-19	BUY	150	11.810	11.010	11.090	USD 1,664	8.67
2025-11-18	BUY	900	11.340	10.500	10.584	USD 9,526	8.66
2025-11-17	BUY	300	11.500	10.770	10.843	USD 3,253	8.65
2025-11-14	BUY	150	12.490	10.700	10.879	USD 1,632	8.64
2025-11-12	BUY	150	11.310	10.610	10.680	USD 1,602	8.62
2025-11-10	BUY	150	10.500	9.950	10.005	USD 1,501	8.60
2025-11-06	BUY	150	10.412	9.865	9.920	USD 1,488	8.58
2025-11-04	BUY	151	10.170	8.830	8.964	USD 1,354	8.57
2025-10-30	BUY	755	10.672	10.200	10.247	USD 7,737	8.54
2025-10-29	BUY	302	10.260	10.735	10.687	USD 3,228	8.53
2025-10-22	SELL	-600	9.280	9.650	9.613	USD -5,768	8.49 Loss of -673 on sale
2025-10-20	BUY	300	9.990	10.405	10.363	USD 3,109	8.48
2025-10-17	BUY	749	9.840	10.200	10.164	USD 7,613	8.47
2025-10-15	BUY	1,192	10.290	10.340	10.335	USD 12,319	8.46
2025-10-03	BUY	1,057	9.570	9.745	9.727	USD 10,282	8.44
2025-10-02	BUY	151	9.140	9.372	9.349	USD 1,412	8.44
2025-09-30	BUY	302	8.850	9.040	9.021	USD 2,724	8.43
2025-09-26	BUY	302	9.050	9.130	9.122	USD 2,755	8.43
2025-09-25	BUY	302	8.360	8.425	8.419	USD 2,542	8.43
2025-09-18	BUY	153	8.440	8.500	8.494	USD 1,300	8.43
2025-09-17	BUY	459	8.090	8.580	8.531	USD 3,916	8.43
2025-09-11	SELL	-152	8.825	8.850	8.848	USD -1,345	8.43 Loss of -64 on sale
2025-09-10	BUY	304	8.170	8.900	8.827	USD 2,683	8.43
2025-07-17	SELL	-300	6.600	6.695	6.686	USD -2,006	8.47 Profit of 535 on sale
2025-07-11	SELL	-1,208	6.280	6.505	6.483	USD -7,831	8.53 Profit of 2,469 on sale
2025-07-02	BUY	8,360	5.810	5.995	5.976	USD 49,964	8.59
2025-06-25	BUY	302	5.800	5.970	5.953	USD 1,798	8.67
2025-06-20	BUY	4,513	5.850	6.110	6.084	USD 27,457	8.73
2025-06-11	BUY	274	6.920	7.110	7.091	USD 1,943	8.86
2025-06-10	BUY	274	6.810	7.020	6.999	USD 1,918	8.87
2025-06-04	SELL	-137	6.450	6.650	6.630	USD -908	8.94 Profit of 317 on sale
2025-04-23	BUY	136	6.370	6.600	6.577	USD 894	9.81
2025-04-10	SELL	-1,088	5.630	5.860	5.837	USD -6,351	10.20 Profit of 4,751 on sale
2025-04-08	SELL	-136	5.620	6.120	6.070	USD -826	10.31 Profit of 576 on sale
2025-04-07	SELL	-136	5.760	6.020	5.994	USD -815	10.36 Profit of 594 on sale
2025-04-04	SELL	-685	5.890	6.160	6.133	USD -4,201	10.41 Profit of 2,930 on sale
2025-04-01	BUY	556	6.380	6.580	6.560	USD 3,647	10.51
2025-03-31	SELL	-411	6.600	6.950	6.915	USD -2,842	10.55 Profit of 1,496 on sale
2025-03-21	BUY	3,380	7.840	8.040	8.020	USD 27,108	10.81
2025-03-14	SELL	-2,032	7.140	7.490	7.455	USD -15,149	11.05 Profit of 7,306 on sale
2025-03-07	SELL	-252	7.530	7.740	7.719	USD -1,945	11.33 Profit of 909 on sale
2025-03-04	SELL	-127	7.330	7.430	7.420	USD -942	11.51 Profit of 519 on sale
2025-02-25	BUY	254	7.880	7.960	7.952	USD 2,020	11.84
2025-02-19	SELL	-126	8.290	8.320	8.317	USD -1,048	12.12 Profit of 479 on sale
2025-02-13	BUY	375	8.280	8.500	8.478	USD 3,179	12.43
2025-02-12	BUY	125	8.350	8.390	8.386	USD 1,048	12.51
2025-02-11	BUY	500	8.340	8.850	8.799	USD 4,400	12.60
2024-12-30	SELL	-3,449	8.510	8.670	8.654	USD -29,848	14.53 Profit of 20,278 on sale
2024-11-18	SELL	-1,968	16.040	16.680	16.616	USD -32,700	17.51 Profit of 1,768 on sale
2024-11-08	SELL	-131	17.680	17.960	17.932	USD -2,349	17.43 Loss of -66 on sale
2024-10-21	SELL	-132	17.700	17.970	17.943	USD -2,368	0.00 Loss of -2,368 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of KURA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	234,399	0	427,530	54.8%
2025-09-18	192,677	0	461,708	41.7%
2025-09-17	227,748	0	484,325	47.0%
2025-09-16	207,049	0	472,165	43.9%
2025-09-15	220,322	59	504,331	43.7%
2025-09-12	257,700	0	540,786	47.7%
2025-09-11	407,206	1,200	815,863	49.9%
2025-09-10	1,435,533	2,105	2,252,666	63.7%
2025-09-09	165,789	0	283,983	58.4%
2025-09-08	251,948	0	585,457	43.0%
2025-09-05	175,775	0	433,954	40.5%
2025-09-04	287,875	30,282	546,302	52.7%
2025-09-03	332,684	0	592,290	56.2%
2025-09-02	336,449	130	763,248	44.1%
2025-08-29	265,324	0	500,477	53.0%
2025-08-28	1,002,337	0	1,540,031	65.1%
2025-08-27	245,171	0	535,688	45.8%
2025-08-26	100,272	0	269,777	37.2%
2025-08-25	216,125	0	430,411	50.2%
2025-08-22	272,869	0	977,450	27.9%
2025-08-21	358,015	1	898,882	39.8%
2025-08-20	113,840	0	512,379	22.2%
2025-08-19	250,015	5,166	633,912	39.4%
2025-08-18	511,131	1,032	1,191,130	42.9%
2025-08-15	866,299	6,790	2,113,207	41.0%
2025-08-14	126,430	0	489,959	25.8%
2025-08-13	254,356	600	697,349	36.5%
2025-08-12	426,309	2,800	816,659	52.2%
2025-08-11	417,144	200	889,478	46.9%
2025-08-08	963,351	4,121	1,751,427	55.0%
2025-08-07	166,955	0	374,936	44.5%
2025-08-06	218,670	2	476,662	45.9%
2025-08-05	226,666	802	574,955	39.4%
2025-08-04	223,259	0	576,655	38.7%
2025-08-01	126,216	0	495,118	25.5%
2025-07-31	120,920	0	322,606	37.5%
2025-07-30	158,181	0	502,323	31.5%
2025-07-29	132,576	1,502	553,994	23.9%
2025-07-28	68,248	1,500	281,103	24.3%
2025-07-25	165,945	0	415,801	39.9%
2025-07-24	159,691	73	379,848	42.0%
2025-07-23	124,341	0	525,032	23.7%
2025-07-22	103,797	394	371,309	28.0%
2025-07-21	110,374	0	332,339	33.2%
2025-07-18	139,859	0	341,378	41.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE